Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...
Insider buying surged in February. Warren Buffett continues to build a stake in a media stock, and IPOs tempted some insiders ...
GT Medical Technologies, announced that it has raised $37 million in Series D financing round. The financing round was led ...
Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...
Digital health firms in the city raised $4 billion in 2024, up 60% from the previous year, according to a report released ...
The gross proceeds from the initial public offering are expected to be approximately $191 million, before deducting underwriting discounts and commissions and other offering expenses, and excluding ...
Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...
Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback